TY - JOUR
T1 - Outpatient management of uncomplicated enteric fever
T2 - A case series of 93 patients from the Hospital of Tropical Diseases, London
AU - McCann, N.
AU - Nabarro, L.
AU - Morris-Jones, S.
AU - Patel, T.
AU - Godbole, G.
AU - Heyderman, R.
AU - Brown, M.
N1 - Publisher Copyright:
© 2022
PY - 2022/10/1
Y1 - 2022/10/1
N2 - Objectives: Enteric fever is predominantly managed as an outpatient condition in endemic settings but there is little evidence to support this approach in non-endemic settings. This study aims to review the outcomes of outpatients treated for enteric fever at the Hospital of Tropical Diseases in London, UK. Methods: We conducted a retrospective analysis of all patients with confirmed enteric fever between August 2009 and September 2020. Demographic, clinical, laboratory and microbiological data were collected and compared between the inpatient and outpatient populations. Outcomes investigated were complicated enteric fever, treatment failure and relapse. Results: Overall, 93 patients (59% male, median age 31) were identified with blood and/or stool culture confirmed enteric fever and 49 (53%) of these were managed as outpatients. The commonest empirical treatment for outpatients was azithromycin (70%) and for inpatients was ceftriaxone (84%). Outpatients were more likely than inpatients to receive only one antibiotic (57% vs 19%, p < 0.01) and receive a shorter duration of antibiotics (median 7 vs 11 days, p <0.01). There were no cases of complicated disease or relapse in either the inpatient or outpatient groups. There was one treatment failure in the outpatient group. Azithromycin was well-tolerated with no reported side effects. Conclusions: Our findings suggest that outpatient management of uncomplicated imported enteric fever is safe and effective with the use of oral azithromycin. Careful monitoring of patients is recommended as treatment failure can occur.
AB - Objectives: Enteric fever is predominantly managed as an outpatient condition in endemic settings but there is little evidence to support this approach in non-endemic settings. This study aims to review the outcomes of outpatients treated for enteric fever at the Hospital of Tropical Diseases in London, UK. Methods: We conducted a retrospective analysis of all patients with confirmed enteric fever between August 2009 and September 2020. Demographic, clinical, laboratory and microbiological data were collected and compared between the inpatient and outpatient populations. Outcomes investigated were complicated enteric fever, treatment failure and relapse. Results: Overall, 93 patients (59% male, median age 31) were identified with blood and/or stool culture confirmed enteric fever and 49 (53%) of these were managed as outpatients. The commonest empirical treatment for outpatients was azithromycin (70%) and for inpatients was ceftriaxone (84%). Outpatients were more likely than inpatients to receive only one antibiotic (57% vs 19%, p < 0.01) and receive a shorter duration of antibiotics (median 7 vs 11 days, p <0.01). There were no cases of complicated disease or relapse in either the inpatient or outpatient groups. There was one treatment failure in the outpatient group. Azithromycin was well-tolerated with no reported side effects. Conclusions: Our findings suggest that outpatient management of uncomplicated imported enteric fever is safe and effective with the use of oral azithromycin. Careful monitoring of patients is recommended as treatment failure can occur.
KW - Antimicrobial resistance
KW - Enteric fever
KW - Outpatient
KW - Returning travellers
KW - Salmonella paratyphi
KW - Salmonella typhi
UR - https://www.scopus.com/pages/publications/85134742081
U2 - 10.1016/j.jinf.2022.06.025
DO - 10.1016/j.jinf.2022.06.025
M3 - Article
C2 - 35781016
AN - SCOPUS:85134742081
SN - 0163-4453
VL - 85
SP - 397
EP - 404
JO - Journal of Infection
JF - Journal of Infection
IS - 4
ER -